Voiceline Transforms Field Sales with €2.4 Million Seed Funding: AI-Driven Automation Reduces Administrative Burden by 80%

Munich-based AI startup Voiceline has successfully concluded its Seed funding round, raising €2.4 million and elevating its total funding to €4.2 million. This new capital infusion marks a significant milestone for the company as it aims to redefine field sales operations through cutting-edge technology. In an era where digital tools are reshaping business landscapes, the…

Read More

Hebbia Raises $130 Million to Supercharge Enterprise Knowledge Retrieval with AI

Big bucks for brains! New York AI startup Hebbia just landed a cool $130 million in Series B funding, a war chest to revolutionize how businesses find information. Tech titans Andreessen Horowitz and Index Ventures led the round, with heavy hitters like Peter Thiel and Google’s venture arm joining the party. This investment spree signifies…

Read More

PolTREG Reports Long-Term Success in Type-1 Diabetes Treatment Study

PolTREG S.A., a pioneering biotechnology firm specializing in cellular therapies for autoimmune disorders, has announced groundbreaking findings from its long-term clinical study on PTG-007, a polyclonal Treg cell therapy for early-onset type-1 diabetes (T1D). Over a span of 7 to 12 years, pediatric patients treated with PTG-007 demonstrated sustained insulin secretion, contrasting starkly with a…

Read More

Freeflow Ventures Secures $90 Million to Drive Early Stage Deep Tech Innovations

In a significant move bolstering its commitment to advancing science-driven solutions, Freeflow Ventures has announced the successful raise of $90 million in funding. This includes $50 million from its Fund Two and Opportunity Fund, complementing its existing $25 million Fund One and Special Purpose Vehicles (SPVs). Amidst a challenging venture capital landscape, Freeflow’s doubled fundraising…

Read More
Roee Barak, Founder and CEO of Upword

Revolutionizing Research: Upword Launches AI-Powered Tool and Secures $3 Million in Funding

Upword, a pioneering force in knowledge management solutions, has unveiled its cutting-edge AI-powered research companion tool, marking a pivotal moment in the evolution of scholarly pursuits. Alongside this milestone, the company has successfully concluded a $3 million pre-seed funding round, underscoring confidence from investors including Telefonica (Wayra X), Go Ahead Ventures, and Goodwater Capital. Upword’s…

Read More

Helpt Secures $850,000 Seed Funding to Expand Technical Support Solutions

Helpt, a U.S.-based leader in technical and customer service solutions, has successfully raised $850,000 in seed funding from Dealbrook Holdings II. This significant investment will accelerate Helpt’s growth by expanding its service offerings, advancing platform development, and enhancing its sales and marketing efforts. Founded in 2022 by Matthew Pincus and David Sohn, Helpt delivers a…

Read More

PLATMA Secures $2M Pre-Seed Funding for Revolutionary AI-Driven No-Code Platform

PLATMA, an innovative force in the no-code development space, has successfully secured $2 million in pre-seed funding to further advance its AI-powered platform. The Ukrainian-origin startup, which is now valued at $20 million, is setting new standards in the industry by translating natural language directly into functional code. The core of PLATMA’s technology lies in…

Read More

One Data Secures €32M Series B Extension to Propel AI-Powered Data Management Solutions

German data management innovator, One Data, has achieved a significant milestone with a €32 million Series B extension round, co-led by prominent European deep tech and software investors Vsquared Ventures, Molten Ventures, and HV Capital. Founded in 2012, One Data specializes in AI-powered data product builders, revolutionizing how businesses create, manage, and distribute data products…

Read More

BridGene Biosciences Secures $28 Million Series B+ to Propel Next-Gen Oncology and Autoimmune Therapeutics

BridGene Biosciences, a San Jose–based biotech innovator focused on tackling traditionally “undruggable” molecular targets, has raised $28 million in a Series B+ funding round led by Bayland Capital. This capital injection will accelerate clinical advancement of BridGene’s lead candidate, BGC-515—a covalent TEAD inhibitor aimed at solid tumors—and fuel expansion of its proprietary IMTAC™ chemoproteomic platform…

Read More

Iteris Pioneering Smart Mobility Embraces New Chapter with Almaviva Acquisition

Iteris, Inc., a global leader in smart mobility infrastructure management, announced today a definitive agreement to be acquired by Almaviva S.p.A., a leading Italian digital innovation group, in an all-cash transaction valued at approximately $335 million. This strategic move marks a significant milestone for Iteris, solidifying its position at the forefront of intelligent transportation solutions….

Read More